EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 85 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,917,911 | -11.2% | 1,746,868 | +76.4% | 0.01% | 0.0% |
| Q2 2022 | $7,794,000 | -57.3% | 990,036 | -34.1% | 0.01% | -44.4% |
| Q1 2022 | $18,247,000 | -10.9% | 1,502,780 | -10.1% | 0.01% | 0.0% |
| Q4 2021 | $20,469,000 | +176.3% | 1,671,183 | +134.6% | 0.01% | +200.0% |
| Q3 2021 | $7,409,000 | +23.8% | 712,384 | +7.2% | 0.00% | 0.0% |
| Q2 2021 | $5,984,000 | -12.7% | 664,498 | -1.3% | 0.00% | 0.0% |
| Q1 2021 | $6,858,000 | +4942.6% | 673,385 | +3163.2% | 0.00% | – |
| Q4 2020 | $136,000 | – | 20,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |